Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: A comparison between hollow fiber and flat sheet membrane oxygenators

被引:25
作者
Gu, YJ
Boonstra, PW
Graaff, R
Rijnsburger, AA
Mungroop, H
van Oeveren, W
机构
[1] Univ Groningen Hosp, Dept Cardiothorac Surg, Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Organ Technol, Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Anesthesiol, Groningen, Netherlands
关键词
pressure drop; shear stress; leukocytes; elastase; oxygenator; cardiopulmonary bypass;
D O I
10.1046/j.1525-1594.2000.06351.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The membrane oxygenator is known to be superior to the bubble oxygenator, but little information is available about the difference between the hollow fiber and flat sheet membrane oxygenators with regard to pressure drop, shear stress, and leukocyte activation. In this study, we compared these 2 types of membrane oxygenators in patients undergoing cardiopulmonary bypass (CPB) surgery with special focus on leukocyte activation and pressure drop across the oxygenators. Plasma concentration of elastase, a marker indicating leukocyte activation, increased to 593 +/- 68% in the flat sheet oxygenator group versus 197 +/- 42% in the hollow fiber oxygenator group (p < 0.01) at the end of CPB compared to their respective baseline concentrations before CPB. Pressure drop across the oxygenator was significantly higher in the flat sheet group than in the hollow fiber group throughout the entire period of CPB (p < 0.01). High pressure drop across the oxygenator as well as the calculated shear stress was positively correlated with the release of elastase at the end of CPB (r = 0.760, p < 0.01, r = 0.692, p < 0.01). However, this positive correlation existed in the flat sheet oxygenator but not in the hollow fiber oxygenator. Clinically, both membrane oxygenators have satisfactory performance in O-2 and CO2 transfer. These results suggest that a higher pressure drop across the flat sheet oxygenator is associated with more pronounced activation of leukocytes in patients undergoing cardiopulmonary bypass.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 20 条
[1]  
BOONSTRA P W, 1992, Perfusion (London), V7, P109, DOI 10.1177/026765919200700205
[2]   HEMATOLOGICAL ADVANTAGE OF A MEMBRANE-OXYGENATOR OVER A BUBBLE OXYGENATOR IN LONG PERFUSIONS [J].
BOONSTRA, PW ;
VERMEULEN, FEE ;
LEUSINK, JA ;
DENOOY, EH ;
VANZALK, A ;
SOONS, JBJ ;
WILDEVUUR, CRH .
ANNALS OF THORACIC SURGERY, 1986, 41 (03) :297-300
[3]   INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS [J].
BUTLER, J ;
ROCKER, GM ;
WESTABY, S .
ANNALS OF THORACIC SURGERY, 1993, 55 (02) :552-559
[4]  
CLARK RE, 1979, J THORAC CARDIOV SUR, V78, P655
[5]   Impact of oxygenator design on hemolysis, shear stress, and white blood cell and platelet counts [J].
DeSomer, F ;
Foubert, L ;
Vanackere, M ;
Dujardin, D ;
Delanghe, J ;
VanNooten, G .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1996, 10 (07) :884-889
[6]  
DREYER WJ, 1995, CARDIOVASC RES, V29, P775, DOI 10.1016/0008-6363(96)88612-3
[7]   NEUTROPHIL ADHESION MOLECULE EXPRESSION DURING CARDIOPULMONARY BYPASS WITH BUBBLE AND MEMBRANE OXYGENATORS [J].
GILLINOV, AM ;
BATOR, JM ;
ZEHR, KJ ;
REDMOND, JM ;
BURCH, RM ;
KO, C ;
WINKELSTEIN, JA ;
STUART, RS ;
BAUMGARTNER, WA ;
CAMERON, DE .
ANNALS OF THORACIC SURGERY, 1993, 56 (04) :847-853
[8]   BLOOD COMPATIBILITY OF 2 DIFFERENT TYPES OF MEMBRANE-OXYGENATOR DURING CARDIOPULMONARY BYPASS IN INFANTS [J].
GU, YJ ;
BOONSTRA, PW ;
AKKERMAN, C ;
MUNGROOP, H ;
TIGCHELAAR, I ;
VANOEVEREN, W .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1994, 17 (10) :543-548
[9]   LEUKOCYTE ACTIVATION WITH INCREASED EXPRESSION OF CR3 RECEPTORS DURING CARDIOPULMONARY BYPASS [J].
GU, YJ ;
VANOEVEREN, W ;
BOONSTRA, PW ;
DEHAAN, J ;
WILDEVUUR, CRH .
ANNALS OF THORACIC SURGERY, 1992, 53 (05) :839-843
[10]   NEUTROPHIL CHEMOATTRACTANTS GENERATED IN 2 PHASES DURING REPERFUSION OF ISCHEMIC MYOCARDIUM IN THE RABBIT - EVIDENCE FOR A ROLE FOR C5A AND INTERLEUKIN-8 [J].
IVEY, CL ;
WILLIAMS, FM ;
COLLINS, PD ;
JOSE, PJ ;
WILLIAMS, TJ .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2720-2728